IN2014MU01196A - - Google Patents

Info

Publication number
IN2014MU01196A
IN2014MU01196A IN1196MU2014A IN2014MU01196A IN 2014MU01196 A IN2014MU01196 A IN 2014MU01196A IN 1196MU2014 A IN1196MU2014 A IN 1196MU2014A IN 2014MU01196 A IN2014MU01196 A IN 2014MU01196A
Authority
IN
India
Prior art keywords
compound
formula
preparation
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Sanjay Raikar
Laxmikant Pavase
Ravindra Dattatraya Yeole
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/067330 priority Critical patent/WO2015150890A1/en
Priority to IN1196MU2014 priority patent/IN2014MU01196A/en
Publication of IN2014MU01196A publication Critical patent/IN2014MU01196A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1196MU2014 2014-03-29 2014-12-25 IN2014MU01196A (nl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/067330 WO2015150890A1 (en) 2014-03-29 2014-12-25 A process for preparation of trans-sulfuric acid mono-{2-(5-(3-amino-propyl)-[1,3,4]oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo [3.2.1] oct-6-yl}ester
IN1196MU2014 IN2014MU01196A (nl) 2014-03-29 2014-12-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1196MU2014 IN2014MU01196A (nl) 2014-03-29 2014-12-25

Publications (1)

Publication Number Publication Date
IN2014MU01196A true IN2014MU01196A (nl) 2015-10-02

Family

ID=54239456

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1196MU2014 IN2014MU01196A (nl) 2014-03-29 2014-12-25

Country Status (2)

Country Link
IN (1) IN2014MU01196A (nl)
WO (1) WO2015150890A1 (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019144912A1 (zh) 2018-01-25 2019-08-01 苏州信诺维医药科技有限公司 β-内酰胺酶抑制剂及其用途
CA3238268A1 (en) * 2021-11-17 2023-05-25 Xufan WANG ?-lactamase inhibitor intermediate and preparation method therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2666774T3 (en) * 2008-01-18 2015-03-23 Merck Sharp & Dohme Beta-lactamase INHIBITORS
CA2845108C (en) * 2011-08-30 2015-06-16 Wockhardt Limited 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
US8933233B2 (en) * 2012-03-30 2015-01-13 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

Also Published As

Publication number Publication date
WO2015150890A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
NZ726356A (en) Processes for preparing antiviral compounds
GR20140100479A (el) Συνθεση λιραγλουτιδης
AU2016277367A8 (en) Aryl sulfonohydrazides
IN2014CH00247A (nl)
MX369501B (es) Proceso para la preparación de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
MX2016010973A (es) Compuestos de aminocarbonilcarbamato.
MX2016015543A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles a partir de hexafluoropropeno.
MA39843A (fr) Pyridine-2-amides utiles comme agonistes de cb2
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
IN2014MU01192A (nl)
IN2014MU00195A (nl)
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
IN2014MU00194A (nl)
IN2014MU01196A (nl)
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017002609A (es) Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso.
IN2014CH00444A (nl)
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos
IN2014MU00858A (nl)
IN2014MU01195A (nl)
IN2014MU00072A (nl)